Literature DB >> 19224819

Lidocaine injection into the rat dorsal root ganglion causes neuroinflammation.

Livia Puljak1, Sanja Lovric Kojundzic, Quinn H Hogan, Damir Sapunar.   

Abstract

BACKGROUND: Injury of a spinal nerve or dorsal root ganglion (DRG) during selective spinal nerve blocks is a potentially serious complication that has not been adequately investigated. Our hypothesis was that local anesthetic injection into these structures may result in an inflammatory response and hyperalgesia.
METHODS: We evaluated inflammatory and behavioral responses after injection of 4 microL lidocaine or saline into the L5 spinal nerve or DRG of rats after partial laminectomy. Behavioral testing was performed before and after surgery to examine hyperalgesia in response to nociceptive mechanical stimulation of the foot. DRGs were harvested and stained, and rings of immunoreactive glial cells around neurons were counted.
RESULTS: Animals demonstrated hyperalgesia on the ipsilateral paw up to 4 days after lidocaine injection into the DRG but not after injection into the spinal nerve. The number of glial fibrillary acid protein immunopositive glial cell rings, which represent activation of satellite cells, significantly increased in DRGs after injection of lidocaine into either the DRG or the spinal nerve. The number of glial fibrillary acid protein-positive cells in the lidocaine-injected group was significantly larger than in the saline-injected group. Sporadic OX-42 immunopositive cells, which represent activated microglia, were also seen in lidocaine-injected DRGs. Testing for Pan-T expression, which labels activated T lymphocytes, showed no positive cells.
CONCLUSIONS: Lidocaine injection into the DRG may produce hyperalgesia, possibly due to activation of resident satellite glial cells. In a clinical setting, local anesthetic injection into the DRG should be avoided during selective spinal nerve blocks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224819      PMCID: PMC2869284          DOI: 10.1213/ane.0b013e318193873e

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  29 in total

1.  Intraneural injection during anterior approach for sciatic nerve block.

Authors:  Xavier Sala-Blanch; Jaume Pomés; Purificación Matute; Josep Valls-Solé; Anna Carrera; Xavier Tomás; Anna I García-Diez
Journal:  Anesthesiology       Date:  2004-10       Impact factor: 7.892

2.  Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve.

Authors:  Ping Hu; Alison L Bembrick; Kevin A Keay; Elspeth M McLachlan
Journal:  Brain Behav Immun       Date:  2006-12-21       Impact factor: 7.217

3.  Selective nerve root blocks for the treatment of sciatica: evaluation of injection site and effectiveness--a study with patients and cadavers.

Authors:  C W Pfirrmann; P A Oberholzer; M Zanetti; N Boos; D J Trudell; D Resnick; J Hodler
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

4.  Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment.

Authors:  B A Winkelstein; M D Rutkowski; S M Sweitzer; J L Pahl; J A DeLeo
Journal:  J Comp Neurol       Date:  2001-10-15       Impact factor: 3.215

5.  Nerve injection injury with local anesthetic agents: a light and electron microscopic, fluorescent microscopic, and horseradish peroxidase study.

Authors:  F Gentili; A R Hudson; D Hunter; D G Kline
Journal:  Neurosurgery       Date:  1980-03       Impact factor: 4.654

6.  Diagnostic lumbosacral segmental nerve blocks with local anesthetics: a prospective double-blind study on the variability and interpretation of segmental effects.

Authors:  A P Wolff; G J Groen; B J Crul
Journal:  Reg Anesth Pain Med       Date:  2001 Mar-Apr       Impact factor: 6.288

7.  Continuous sacral nerve root block in the management of neuropathic cancer pain.

Authors:  Jan H Vranken; Marinus H Van Der Vegt; Leon H Ubags; Aarnout J Pijl; Misa Dzoljic
Journal:  Anesth Analg       Date:  2002-12       Impact factor: 5.108

Review 8.  ATP- and adenosine-mediated signaling in the central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4.

Authors:  Kazuhide Inoue; Makoto Tsuda; Schuichi Koizumi
Journal:  J Pharmacol Sci       Date:  2004-02       Impact factor: 3.337

9.  Detection of neuropathic pain in a rat model of peripheral nerve injury.

Authors:  Quinn Hogan; Damir Sapunar; Ksenija Modric-Jednacak; J Bruce McCallum
Journal:  Anesthesiology       Date:  2004-08       Impact factor: 7.892

10.  Local anesthetics: importance of mode of application, concentration and adrenaline for the appearance of nerve lesions. An experimental study of axonal degeneration and barrier damage after intrafascicular injection or topical application of bupivacaine (Marcain).

Authors:  D Selander; R Brattsand; G Lundborg; C Nordborg; Y Olsson
Journal:  Acta Anaesthesiol Scand       Date:  1979-04       Impact factor: 2.105

View more
  8 in total

1.  Glial fibrillary acidic protein promoter determines transgene expression in satellite glial cells following intraganglionic adeno-associated virus delivery in adult rats.

Authors:  Hongfei Xiang; Hao Xu; Fan Fan; Seung-Min Shin; Quinn H Hogan; Hongwei Yu
Journal:  J Neurosci Res       Date:  2017-09-23       Impact factor: 4.164

Review 2.  Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain.

Authors:  Temugin Berta; Yawar Qadri; Ping-Heng Tan; Ru-Rong Ji
Journal:  Expert Opin Ther Targets       Date:  2017-05-16       Impact factor: 6.902

3.  Targeted delivery of pharmacological agents into rat dorsal root ganglion.

Authors:  Livia Puljak; Sanja Lovric Kojundzic; Quinn H Hogan; Damir Sapunar
Journal:  J Neurosci Methods       Date:  2008-11-06       Impact factor: 2.390

4.  Dorsal root ganglion - a potential new therapeutic target for neuropathic pain.

Authors:  Damir Sapunar; Sandra Kostic; Adriana Banozic; Livia Puljak
Journal:  J Pain Res       Date:  2012-02-16       Impact factor: 3.133

5.  Region-Resolved Quantitative Proteome Profiling Reveals Molecular Dynamics Associated With Chronic Pain in the PNS and Spinal Cord.

Authors:  Allison M Barry; Julia R Sondermann; Jan-Hendrik Sondermann; David Gomez-Varela; Manuela Schmidt
Journal:  Front Mol Neurosci       Date:  2018-08-14       Impact factor: 5.639

Review 6.  Peripheral Neuropathic Pain: From Experimental Models to Potential Therapeutic Targets in Dorsal Root Ganglion Neurons.

Authors:  Ti-Yen Yeh; I-Wei Luo; Yu-Lin Hsieh; To-Jung Tseng; Hao Chiang; Sung-Tsang Hsieh
Journal:  Cells       Date:  2020-12-21       Impact factor: 6.600

7.  Lidocaine Ameliorates Diabetic Peripheral Neuropathy in Streptozotocin-Induced Diabetic Rats through Modulating the c-Jun Signaling Pathway.

Authors:  Jinyu Luo; Dedan Wu; Qianming Wu; Yan Chen; Yong Gan; Meng He; Wenyangming Sun; Yiqin Ai; Qiuping Su; Xiaohua Zou; Dashou Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-08-17       Impact factor: 3.009

8.  Gene therapy for neuropathic pain by silencing of TNF-α expression with lentiviral vectors targeting the dorsal root ganglion in mice.

Authors:  Nobuhiro Ogawa; Hiromichi Kawai; Tomoya Terashima; Hideto Kojima; Kazuhiro Oka; Lawrence Chan; Hiroshi Maegawa
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.